Pulmonx Co. (NASDAQ:LUNG) Receives $14.17 Consensus PT from Analysts
Pulmonx Co. (NASDAQ:LUNG – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages […]
More Stories
StockNews.com Downgrades Brightcove (NASDAQ:BCOV) to Buy
StockNews.com cut shares of Brightcove (NASDAQ:BCOV – Free Report) from a strong-buy rating to a buy rating in a research...
StockNews.com Upgrades Team (NYSE:TISI) to “Strong-Buy”
StockNews.com upgraded shares of Team (NYSE:TISI – Free Report) from a buy rating to a strong-buy rating in a research...
Chicago Rivet & Machine (NYSEAMERICAN:CVR) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a report published on Wednesday...
Aeries Technology (AERT) & Its Competitors Head-To-Head Comparison
Profitability This table compares Aeries Technology and its peers’ net margins, return on equity and return on assets. Net Margins...
Insider Selling: Secure Energy Services Inc. (TSE:SES) Insider Sells 2,995 Shares of Stock
Secure Energy Services Inc. (TSE:SES – Get Free Report) insider David Bonderman sold 2,995 shares of the company’s stock in...
Tensions Rise Over ICC Arrest Warrants for Netanyahu, Gallant as US Allies Mull Response
By Tom Ozimek Controversy is intensifying and the stakes are rising over the International Criminal Court’s (ICC) recent decision to...